COMMUNIQUÉS West-GlobeNewswire

Tilray Medical salue le Bundestag allemand et l’adoption historique de la loi sur le cannabis à usage médicinal en Allemagne
24/02/2024
La nouvelle loi allemande sur le cannabis à usage médicinal (Medizinal-Cannabisgesetz – « MedCanG ») permet aux patients d’accéder plus facilement à ce produit COLOGNE, Allemagne et NEUMÜNSTER, Allemagne, 24 févr. 2024 [...]
Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®
24/02/2024
SIMLANDI is t he first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S . SIMLANDI is the first biosimilar approval under the strategic partnership between Alvotech and [...]
Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®
24/02/2024
SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first biosimilar approval under the strategic partnership between Alvotech and [...]
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
23/02/2024
Company Announcement COPENHAGEN, Denmark; February 23, 2024 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document [...]
Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab
23/02/2024
Company Announcement COPENHAGEN, Denmark; February 23, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that the board decided to grant 418,646 restricted stock units to members of management and employees of the [...]
Coherus BioSciences Announces New Employment Inducement Grants
23/02/2024
REDWOOD CITY, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective February 20, 2024, the compensation committee of the Company’s [...]
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23/02/2024
EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
Celularity Announces 1-for-10 Reverse Stock Split
23/02/2024
FLORHAM PARK, N.J., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Celularity, Inc. (Nasdaq: CELU; CELUW) (“Celularity”), a biotechnology company developing allogeneic cell therapies and advanced biomaterial products, today [...]
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23/02/2024
NOVATO, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare [...]
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
23/02/2024
MALVERN, Pa., Feb. 23, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that [...]
Ibogaine By David Dardashti Unravels the Science of Glial Cells
23/02/2024
Research Reveals Mental Growth Directly Linked to Emotional Responses MIAMI, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a scientific research organization based in the United States, is excited to [...]
IBEX Files Management Proxy Circular for Sale of the Company at $1.45 Per Share
23/02/2024
- Shareholders holding an aggregate of 47.15% of IBEX’s outstanding shares have entered into Support and Voting Agreements with the purchaser - IBEX Board unanimously recommends that shareholders vote FOR the going- [...]
Curia nomme Steve Lavezoli vice-président de sa division Produits biologiques
23/02/2024
ALBANY, New York, 23 févr. 2024 (GLOBE NEWSWIRE) -- Curia, l’un des principaux organismes de recherche, de développement et de fabrication sous contrat, a annoncé aujourd’hui la nomination de Steve Lavezoli au poste de [...]
Starton Therapeutics to Present at BIO CEO & Investor Conference 2024
23/02/2024
PARAMUS, N.J., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary [...]
Press Release: Filing of the 2023 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
23/02/2024
Filing of the 2023 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report Paris, February 23, 2024 . Sanofi announces today the filing of its Form 20-F with the U.S. [...]
Communiqué de presse : Dépôt du Document d’Enregistrement Universel 2023, contenant le Rapport Financier Annuel, et du « Form 20-F » américain
23/02/2024
Dépôt du Document d’Enregistrement Universel 2023, contenant le Rapport Financier Annuel, et du « Form 20-F » américain Paris, le 23 février 2024 . Sanofi annonce avoir déposé son Document d’Enregistrement Universel [...]
Latest Holistic Approach for those Struggling With Chemical Dependency
23/02/2024
The Ibogaine Research Center is conducting comprehensive research on addiction treatments. The group, headed by David Dardashti, comprises specialists in organizational psychology (Gavriel Dardashti), Data Coordination [...]
Tilray Medical Applauds German Bundestag and Landmark Passage of Medical Cannabis Act in Germany
23/02/2024
New Medical Cannabis Act in Germany Provides Easier Access to Medical Cannabis for Patients Through the MedCanG COLOGNE, Germany and NEUMÜNSTER, Germany, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray [...]
VITAS® Healthcare Continues Its Pathway of Success and Promotes Two Key Operations Executives
23/02/2024
MIAMI, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Two executive leaders at VITAS Healthcare have been promoted to top operational roles. Joel Wherley now serves as president and chief operating officer (COO) and Bryan Wysong as [...]

Pages